Form: 10-K

Annual report pursuant to Section 13 and 15(d)

October 30, 1995

EXHIBIT 11

Published on October 30, 1995



EXHIBIT 11



ENZO BIOCHEM, INC.
COMPUTATION OF PER-SHARE EARNINGS
Years ended July 31, 1995, 1994 and 1993




1995 1994* 1993*
---- ----- -----


Primary
Average shares outstanding 20,957,300 20,446,900 18,483,400

Net effect of dilutive stock options
and warrants -- based on the
treasury stock method using average
market price 963,500 1,061,700 --
---------- ---------- -----------

Total 21,920,800 21,508,600 18,483,400
---------- ---------- -----------
---------- ---------- -----------

Income (loss) before extraordinary items $5,618,100 $5,101,200 $(6,376,100)
Extraordinary gain (loss) -- 150,000 (465,600)
---------- ---------- -----------

Net income (loss) $5,618,100 $5,251,200 $(6,841,700)
---------- ---------- -----------
---------- ---------- -----------

Per common and common equivalent share
Income (loss) before extraordinary items $.26 $.23 $(.34)
Extraordinary gain (loss) -- .01 (.03)
---- ---- -----

Net income (loss) $.26 $.24 $(.37)
---- ---- -----
---- ---- -----



* Shares and per share amounts have been adjusted for the 5% stock dividend
declared in fiscal 1995.


E-15